413 related articles for article (PubMed ID: 31717887)
1. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.
Palechor-Ceron N; Krawczyk E; Dakic A; Simic V; Yuan H; Blancato J; Wang W; Hubbard F; Zheng YL; Dan H; Strome S; Cullen K; Davidson B; Deeken JF; Choudhury S; Ahn PH; Agarwal S; Zhou X; Schlegel R; Furth PA; Pan CX; Liu X
Cells; 2019 Oct; 8(11):. PubMed ID: 31717887
[TBL] [Abstract][Full Text] [Related]
2. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells.
Liu X; Ory V; Chapman S; Yuan H; Albanese C; Kallakury B; Timofeeva OA; Nealon C; Dakic A; Simic V; Haddad BR; Rhim JS; Dritschilo A; Riegel A; McBride A; Schlegel R
Am J Pathol; 2012 Feb; 180(2):599-607. PubMed ID: 22189618
[TBL] [Abstract][Full Text] [Related]
3. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.
Timofeeva OA; Palechor-Ceron N; Li G; Yuan H; Krawczyk E; Zhong X; Liu G; Upadhyay G; Dakic A; Yu S; Fang S; Choudhury S; Zhang X; Ju A; Lee MS; Dan HC; Ji Y; Hou Y; Zheng YL; Albanese C; Rhim J; Schlegel R; Dritschilo A; Liu X
Oncotarget; 2017 Apr; 8(14):22741-22758. PubMed ID: 28009986
[TBL] [Abstract][Full Text] [Related]
4. Conditional reprogramming: next generation cell culture.
Wu X; Wang S; Li M; Li J; Shen J; Zhao Y; Pang J; Wen Q; Chen M; Wei B; Kaboli PJ; Du F; Zhao Q; Cho CH; Wang Y; Xiao Z; Wu X
Acta Pharm Sin B; 2020 Aug; 10(8):1360-1381. PubMed ID: 32963937
[TBL] [Abstract][Full Text] [Related]
5. Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.
Liu X; Mondal AM
J Med Virol; 2020 Nov; 92(11):2440-2452. PubMed ID: 32478897
[TBL] [Abstract][Full Text] [Related]
6. Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
Sette G; Salvati V; Giordani I; Pilozzi E; Quacquarini D; Duranti E; De Nicola F; Pallocca M; Fanciulli M; Falchi M; Pallini R; De Maria R; Eramo A
Int J Cancer; 2018 Jul; 143(1):88-99. PubMed ID: 29341112
[TBL] [Abstract][Full Text] [Related]
7. Generation of stable PDX derived cell lines using conditional reprogramming.
Borodovsky A; McQuiston TJ; Stetson D; Ahmed A; Whitston D; Zhang J; Grondine M; Lawson D; Challberg SS; Zinda M; Pollok BA; Dougherty BA; D'Cruz CM
Mol Cancer; 2017 Dec; 16(1):177. PubMed ID: 29212548
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods.
Li D; Thomas C; Shrivastava N; Gersten A; Gadsden N; Schlecht N; Kawachi N; Schiff BA; Smith RV; Rosenblatt G; Augustine S; Gavathiotis E; Burk R; Prystowsky MB; Guha C; Mehta V; Ow TJ
J Med Virol; 2023 Feb; 95(2):e28388. PubMed ID: 36477880
[TBL] [Abstract][Full Text] [Related]
9. Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.
Liu X; Krawczyk E; Suprynowicz FA; Palechor-Ceron N; Yuan H; Dakic A; Simic V; Zheng YL; Sripadhan P; Chen C; Lu J; Hou TW; Choudhury S; Kallakury B; Tang DG; Darling T; Thangapazham R; Timofeeva O; Dritschilo A; Randell SH; Albanese C; Agarwal S; Schlegel R
Nat Protoc; 2017 Feb; 12(2):439-451. PubMed ID: 28125105
[TBL] [Abstract][Full Text] [Related]
10. Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research.
Elbialy A; Kappala D; Desai D; Wang P; Fadiel A; Wang SJ; Makary MS; Lenobel S; Sood A; Gong M; Dason S; Shabsigh A; Clinton S; Parwani AV; Putluri N; Shvets G; Li J; Liu X
Cells; 2024 Jun; 13(12):. PubMed ID: 38920635
[TBL] [Abstract][Full Text] [Related]
11. Conditional reprogramming: Modeling urological cancer and translation to clinics.
Liu W; Ju L; Cheng S; Wang G; Qian K; Liu X; Xiao Y; Wang X
Clin Transl Med; 2020 Jun; 10(2):e95. PubMed ID: 32508060
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.
Correa BRS; Hu J; Penalva LOF; Schlegel R; Rimm DL; Galante PAF; Agarwal S
Sci Rep; 2018 Mar; 8(1):4097. PubMed ID: 29511269
[TBL] [Abstract][Full Text] [Related]
13. Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation.
Daneshdoust D; Yin M; Luo M; Sundi D; Dang Y; Lee C; Li J; Liu X
Cells; 2023 Jun; 12(13):. PubMed ID: 37443748
[TBL] [Abstract][Full Text] [Related]
14. Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.
Gao B; Huang C; Kernstine K; Pelekanou V; Kluger Y; Jiang T; Peters-Hall JR; Coquelin M; Girard L; Zhang W; Huffman K; Oliver D; Kinose F; Haura E; Teer JK; Rix U; Le AT; Aisner DL; Varella-Garcia M; Doebele RC; Covington KR; Hampton OA; Doddapaneni HV; Jayaseelan JC; Hu J; Wheeler DA; Shay JW; Rimm DL; Gazdar A; Minna JD
Oncotarget; 2017 Feb; 8(7):11114-11126. PubMed ID: 28052041
[TBL] [Abstract][Full Text] [Related]
15. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
Cao J; Chan WC; Chow MSS
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
[TBL] [Abstract][Full Text] [Related]
16. Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditions.
Yu F; Lu Y; Tao L; Jiang YY; Lin DC; Wang L; Petersson F; Yoshiyama H; Koeffler PH; Goh BC; Loh KS
Sci Rep; 2017 Dec; 7(1):17359. PubMed ID: 29234119
[TBL] [Abstract][Full Text] [Related]
17. Conditional Cell Reprogramming in Modeling Digestive System Diseases.
Zhao R; Li R; An T; Liu X
Front Cell Dev Biol; 2021; 9():669756. PubMed ID: 34150763
[TBL] [Abstract][Full Text] [Related]
18. Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses.
Liu X; Wu Y; Rong L
Virol Sin; 2020 Jun; 35(3):280-289. PubMed ID: 32557270
[TBL] [Abstract][Full Text] [Related]
19. Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors.
Hynds RE; Ben Aissa A; Gowers KHC; Watkins TBK; Bosshard-Carter L; Rowan AJ; Veeriah S; Wilson GA; Quezada SA; Swanton C; ; Janes SM
Int J Cancer; 2018 Jul; 143(1):160-166. PubMed ID: 29569246
[TBL] [Abstract][Full Text] [Related]
20. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells.
Kettunen K; Boström PJ; Lamminen T; Heinosalo T; West G; Saarinen I; Kaipio K; Rantala J; Albanese C; Poutanen M; Taimen P
Eur Urol; 2019 Oct; 76(4):430-434. PubMed ID: 31256944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
